Antibiotic heteroresistance observed across commensal Lactobacillus species

Lactobacilli are prevalent members of the microbiota in the intestinal and reproductive tracts of humans and other species. They are commonly used in probiotics due to their beneficial effects on human health, including their association with protection from numerous chronic diseases. In addition, these microbes are often prescribed to maintain their presence in the host during antibiotic therapy, as well as to treat diarrhea caused by antibiotics. Despite many studies examining the beneficial effects of lactobacilli, less is known about how they survive during antibiotic treatment, and in particular, whether they exhibit heteroresistance, a phenotype in which only a minor subpopulation of resistant cells coexists with a majority susceptible population. Here, we tested representative Lactobacillus species for heteroresistance to a broad panel of relevant antibiotics. The results demonstrate that Lactobacillus strains, including those isolated from human feces, can exhibit heteroresistance to relevant antibiotics from distinct classes, and are often heteroresistant to fluoroquinolones. In particular, heteroresistance to fluoroquinolones was even observed in Lactobacillus rhamnosus GG, a widely used probiotic. These findings significantly impact our understanding of how lactobacilli, including strains isolated from human samples, can survive antibiotic treatment, and how individual probiotic strains may be selected for use during antibiotic therapy to promote their survival and maximize their benefits. IMPORTANCE Commensal bacteria, such as Lactobacillus species, are widely used for their beneficial effects on gastrointestinal health and their potential to help restore the gut microbial community after antibiotic use. However, the antibiotic resistance profiles of these beneficial bacteria have received limited attention despite their relevance to probiotic use. Heteroresistance is a phenomenon in which a small subpopulation of resistant bacteria within an otherwise susceptible community survives antibiotic exposure, but it is often undetected, underappreciated, and has largely not been investigated among commensal bacteria. Our study provides a characterization of heteroresistance across distinct Lactobacillus species and a panel of antibiotics, revealing that heteroresistance is far more widespread than previously appreciated, especially to fluoroquinolones. These findings suggest probiotic strains could be selected that would survive concurrent antibiotic therapy and thus highlight that more comprehensive resistance profiling of probiotic bacteria may yield benefits to patients.

Authors

Institutions

Publication Details

Journal
Microbiology Spectrum
Published
2026-11-19
DOI
https://doi.org/10.1128/spectrum.00989-26
Citations
4
Primary Topic
Probiotics and Fermented Foods
Type
article
Field-Weighted Citation Impact
7.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Antibiotic heteroresistance observed across commensal Lactobacillus species

David S. Weiss, Michael H. Woodworth, Dormarie E. Rivera-Rodriguez, Luisa Cervantes‐Barragán et al.
4 citations
Microbiology Spectrum
Probiotics and Fermented Foods
7.39
article

Antibiotic heteroresistance observed across commensal Lactobacillus species

David S. Weiss, Michael H. Woodworth, Dormarie E. Rivera-Rodriguez, Luisa Cervantes‐Barragán, Isabelle Gracien, Chayse Busby, Christa Dudley, Eva Li, Abigail Lee
article en
4 citations

Abstract

Lactobacilli are prevalent members of the microbiota in the intestinal and reproductive tracts of humans and other species. They are commonly used in probiotics due to their beneficial effects on human health, including their association with protection from numerous chronic diseases. In addition, these microbes are often prescribed to maintain their presence in the host during antibiotic therapy, as well as to treat diarrhea caused by antibiotics. Despite many studies examining the beneficial effects of lactobacilli, less is known about how they survive during antibiotic treatment, and in particular, whether they exhibit heteroresistance, a phenotype in which only a minor subpopulation of resistant cells coexists with a majority susceptible population. Here, we tested representative Lactobacillus species for heteroresistance to a broad panel of relevant antibiotics. The results demonstrate that Lactobacillus strains, including those isolated from human feces, can exhibit heteroresistance to relevant antibiotics from distinct classes, and are often heteroresistant to fluoroquinolones. In particular, heteroresistance to fluoroquinolones was even observed in Lactobacillus rhamnosus GG, a widely used probiotic. These findings significantly impact our understanding of how lactobacilli, including strains isolated from human samples, can survive antibiotic treatment, and how individual probiotic strains may be selected for use during antibiotic therapy to promote their survival and maximize their benefits. IMPORTANCE Commensal bacteria, such as Lactobacillus species, are widely used for their beneficial effects on gastrointestinal health and their potential to help restore the gut microbial community after antibiotic use. However, the antibiotic resistance profiles of these beneficial bacteria have received limited attention despite their relevance to probiotic use. Heteroresistance is a phenomenon in which a small subpopulation of resistant bacteria within an otherwise susceptible community survives antibiotic exposure, but it is often undetected, underappreciated, and has largely not been investigated among commensal bacteria. Our study provides a characterization of heteroresistance across distinct Lactobacillus species and a panel of antibiotics, revealing that heteroresistance is far more widespread than previously appreciated, especially to fluoroquinolones. These findings suggest probiotic strains could be selected that would survive concurrent antibiotic therapy and thus highlight that more comprehensive resistance profiling of probiotic bacteria may yield benefits to patients.

Microbiology Spectrum
Emory University (US)
Emory University, Sherman Fairchild Foundation, National Institutes of Health, Goizueta Business School, Emory University, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases
Good health and well-being
Openalex Percentile: Top 4%
Probiotics and Fermented Foods
7.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon